Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15Business Wire • 04/03/24
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)Business Wire • 04/02/24
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate UpdatesBusiness Wire • 03/12/24
Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in FebruaryBusiness Wire • 02/01/24
Forget the "Magnificent Seven" -- This Stock Has Nearly Quadrupled in 2024, and Wall Street Thinks It Can Go a Lot HigherThe Motley Fool • 01/17/24
Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional SharesBusiness Wire • 01/08/24
Recent Price Trend in Longboard Pharmaceuticals, Inc. (LBPH) is Your Friend, Here's WhyZacks Investment Research • 01/05/24
Longboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common StockBusiness Wire • 01/04/24
Longboard Pharmaceuticals Announces Commencement of Public Offering of Common StockBusiness Wire • 01/02/24
Longboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)Business Wire • 01/02/24
Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)Business Wire • 01/01/24
Longboard Pharmaceuticals Announces Initiation of First-in-Human Phase 1 Clinical Study of LP659 in Adult Healthy VolunteersBusiness Wire • 11/29/23
Down -25.05% in 4 Weeks, Here's Why You Should You Buy the Dip in Longboard Pharmaceuticals, Inc. (LBPH)Zacks Investment Research • 11/24/23
Longboard Pharmaceuticals' Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy CommunityBusiness Wire • 11/21/23
Wall Street Analysts Believe Longboard Pharmaceuticals, Inc. (LBPH) Could Rally 262.45%: Here's is How to TradeZacks Investment Research • 11/08/23
Longboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Business Wire • 11/03/23
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsBusiness Wire • 11/02/23
Longboard Pharmaceuticals to Present at Three Upcoming Investor Conferences in NovemberBusiness Wire • 11/01/23
Longboard Pharmaceuticals Announces Speakers for Investor & Analyst Event in New York on October 11, 2023Business Wire • 10/05/23
Longboard Pharmaceuticals to Host Investor & Analyst Event in New York on October 11, 2023Business Wire • 09/19/23
Longboard Pharmaceuticals to Participate in Three Upcoming Investor ConferencesBusiness Wire • 08/31/23